Lonza sells capsule and health ingredients unit for $2.2Bnews2026-03-06T19:50:51+00:00March 6th, 2026|Endpoints News|
Novo Nordisk details Irish expansion; EuroAPI’s challenges continuenews2026-03-05T14:23:03+00:00March 5th, 2026|Endpoints News|
WuXi XDC makes an ADC linker deal with Earendil for up to $885Mnews2026-02-27T16:13:26+00:00February 27th, 2026|Endpoints News|
Viatris plans to lay off up to 10% of staff, discloses Indian factory fire news2026-02-26T18:09:12+00:00February 26th, 2026|Endpoints News|
Novartis to build another radioligand factory; Germany steps up probe into Gerresheimer news2026-02-26T14:52:14+00:00February 26th, 2026|Endpoints News|
Charles River sells its CDMO and European discovery businessesnews2026-02-25T16:22:03+00:00February 25th, 2026|Endpoints News|
AbbVie budgets $380M for obesity and neuroscience API facilities in Chicagonews2026-02-23T16:00:44+00:00February 23rd, 2026|Endpoints News|
Supreme Court tariff ruling lets stand Trump’s authority to target pharma news2026-02-20T18:35:54+00:00February 20th, 2026|Endpoints News|
Novartis to divest India unit to private equity-led consortium for $159M news2026-02-20T12:15:13+00:00February 20th, 2026|Endpoints News|
Sanofi to expand in India; Stada invests $100M in Saudi Arabianews2026-02-19T15:42:43+00:00February 19th, 2026|Endpoints News|
